Blood Collection Devices Market By Product (Tubes (Plasma, Serum), Needles & Syringes, Blood Bags, Monitors), Method, Application, End User - Global Forecast to 2030

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY RESEARCH
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY RESEARCH
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key objectives of primary research
    • 2.1.2.3 Key data from primary sources
    • 2.1.2.4 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach 2: Presentations of companies and primary interviews
    • 2.2.1.2 Growth forecast
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 RESEARCH ASSUMPTIONS
  • 2.5.1 PARAMETRIC ASSUMPTIONS
  • 2.5.2 GROWTH RATE ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 BLOOD COLLECTION DEVICES MARKET OVERVIEW
• 4.2 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2025 VS. 2030
• 4.3 BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2025 VS. 2030
• 4.4 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2025 VS. 2030
• 4.5 BLOOD COLLECTION DEVICES MARKET, BY END USER, 2025 VS. 2030
• 4.6 BLOOD COLLECTION DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising prevalence of infectious diseases and chronic & lifestyle diseases
    • 5.2.1.2 Increasing number of hospitals and surgical centers
    • 5.2.1.3 Rise in accidents and trauma cases
    • 5.2.1.4 Emergence of liquid biopsy tests
    • 5.2.1.5 Growing demand for and awareness of blood donations and blood components
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Rising costs of automated blood collection devices
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increasing demand for apheresis
    • 5.2.3.2 Lucrative opportunities in emerging economies
    • 5.2.3.3 Advancements in blood collection
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Complex storage and shipping
    • 5.2.4.2 Lack of skilled professionals
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE TREND, BY PRODUCT
  • 5.4.2 AVERAGE SELLING PRICE TREND OF BLOOD COLLECTION DEVICES, BY KEY PLAYER
  • 5.4.3 AVERAGE SELLING PRICE TREND, BY REGION
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 SUPPLY CHAIN ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 Core blood collection devices
  • 5.9.2 COMPLEMENTARY TECHNOLOGIES
    • 5.9.2.1 Sampling and collection kits
• 5.10 PATENT ANALYSIS
• 5.11 TRADE ANALYSIS
  • 5.11.1 IMPORT DATA
  • 5.11.2 EXPORT DATA
• 5.12 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.13 CASE STUDY ANALYSIS
  • 5.13.1 CASE STUDY 1: REDUCING HOSPITAL-ONSET BACTEREMIA USING PIVO NEEDLELESS BLOOD COLLECTION
  • 5.13.2 CASE STUDY 2: ADOPTION OF PIVO NEEDLE-FREE BLOOD COLLECTION DEVICE AT VIRGINIA MASON MEDICAL CENTER
  • 5.13.3 CASE STUDY 3: AUTONOMOUS BLOOD COLLECTION ENHANCES EFFICIENCY AND PATIENT EXPERIENCE AT ST. ANTONIUS HOSPITAL
• 5.14 REGULATORY ANALYSIS
  • 5.14.1 REGULATORY LANDSCAPE
    • 5.14.1.1 North America
      • 5.14.1.1.1 US
      • 5.14.1.1.2 Canada
    • 5.14.1.2 Europe
      • 5.14.1.2.1 Germany
      • 5.14.1.2.2 UK
      • 5.14.1.2.3 France
      • 5.14.1.2.4 Italy
      • 5.14.1.2.5 Spain
    • 5.14.1.3 Asia Pacific
      • 5.14.1.3.1 China
      • 5.14.1.3.2 Japan
      • 5.14.1.3.3 India
    • 5.14.1.4 Latin America
      • 5.14.1.4.1 Brazil
      • 5.14.1.4.2 Mexico
    • 5.14.1.5 Middle East
    • 5.14.1.6 Africa
  • 5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.15 PORTER'S FIVE FORCES ANALYSIS
  • 5.15.1 BARGAINING POWER OF SUPPLIERS
  • 5.15.2 BARGAINING POWER OF BUYERS
  • 5.15.3 THREAT OF NEW ENTRANTS
  • 5.15.4 THREAT OF SUBSTITUTES
  • 5.15.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.16.2 BUYING CRITERIA
• 5.17 IMPACT OF GENERATIVE AI ON BLOOD COLLECTION DEVICES MARKET
  • 5.17.1 INTRODUCTION
  • 5.17.2 MARKET POTENTIAL FOR BLOOD COLLECTION DEVICES
  • 5.17.3 AI USE CASES
  • 5.17.4 KEY COMPANIES IMPLEMENTING AI
  • 5.17.5 FUTURE OF GENERATIVE AI IN BLOOD COLLECTION DEVICES MARKET
• 5.18 IMPACT OF 2025 US TARIFFS ON BLOOD COLLECTION DEVICES MARKET
  • 5.18.1 INTRODUCTION
  • 5.18.2 KEY TARIFF RATES
  • 5.18.3 PRICE IMPACT ANALYSIS
  • 5.18.4 IMPACT ON COUNTRY/REGION
    • 5.18.4.1 North America
    • 5.18.4.2 Europe
    • 5.18.4.3 Asia Pacific
  • 5.18.5 IMPACT ON END-USE INDUSTRIES
    • 5.18.5.1 Hospitals, ambulatory surgical centers, and nursing homes
    • 5.18.5.2 Diagnostic & pathology labs
    • 5.18.5.3 Blood banks

6 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 BLOOD COLLECTION TUBES
  • 6.2.1 BLOOD COLLECTION TUBES MARKET, BY TYPE
    • 6.2.1.1 Plasma/Whole-blood tubes
      • 6.2.1.1.1 EDTA tubes
      • 6.2.1.1.2 Heparin tubes
      • 6.2.1.1.3 Coagulation tubes
      • 6.2.1.1.4 Glucose tubes
      • 6.2.1.1.5 ESR tubes
    • 6.2.1.2 Serum tubes
      • 6.2.1.2.1 Need for high-quality serum specimens to fuel market
  • 6.2.2 BLOOD COLLECTION TUBES, BY SYSTEM TYPE
    • 6.2.2.1 Vacuum tubes
      • 6.2.2.1.1 Need to minimize blood exposure to promote growth
    • 6.2.2.2 Non-vacuum tubes
      • 6.2.2.2.1 Cost constraints to contribute to growth
• 6.3 NEEDLES & SYRINGES
  • 6.3.1 RISING ADOPTION OF SAFETY BLOOD COLLECTION SETS TO BOLSTER GROWTH
• 6.4 BLOOD BAGS
  • 6.4.1 INCREASING BLOOD DONATIONS WORLDWIDE TO AUGMENT GROWTH
• 6.5 BLOOD COLLECTION SYSTEMS/MONITORS
  • 6.5.1 GROWING CONCERNS REGARDING BLOOD SAFETY AND BLOOD SHORTAGE TO PROPEL MARKET
• 6.6 LANCETS
  • 6.6.1 HIGH CONVENIENCE AND MINIMAL PAIN TO CONTRIBUTE TO GROWTH

7 BLOOD COLLECTION DEVICES MARKET, BY METHOD

• 7.1 INTRODUCTION
• 7.2 MANUAL BLOOD COLLECTION
  • 7.2.1 RISING INCLINATION TOWARD SELF-CARE AND INCREASING NUMBER OF DIAGNOSTIC CENTERS TO DRIVE MARKET
• 7.3 AUTOMATED BLOOD COLLECTION
  • 7.3.1 INCREASING DEMAND FOR SAFER COLLECTION PROCEDURES AND AVAILABILITY OF ADVANCED BLOOD-COLLECTING PRODUCTS TO AID GROWTH

8 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 DIAGNOSTIC APPLICATIONS
  • 8.2.1 RISING INCIDENCE OF INFECTIOUS DISEASES TO SPUR GROWTH
• 8.3 THERAPEUTIC APPLICATIONS
  • 8.3.1 RISING PREVALENCE OF HEMATOLOGICAL DISORDERS TO SUPPORT GROWTH

9 BLOOD COLLECTION DEVICES MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES
  • 9.2.1 INCREASING NUMBER OF SURGICAL PROCEDURES AND HOSPITALS TO FOSTER GROWTH
• 9.3 DIAGNOSTIC & PATHOLOGY LABORATORIES
  • 9.3.1 RISING NUMBER OF TEST VOLUMES TO CONTRIBUTE TO GROWTH
• 9.4 BLOOD BANKS
  • 9.4.1 INCREASING AWARENESS ABOUT BLOOD DONATION AND USE OF BLOOD FOR TREATING CLINICAL CONDITIONS TO BOOST MARKET
• 9.5 OTHER END USERS

10 BLOOD COLLECTION DEVICES MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 High healthcare expenditure and increasing prevalence of cancer to expedite growth
  • 10.2.3 CANADA
    • 10.2.3.1 Growing volume of surgical procedures to support growth
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Increasing healthcare expenditure and new blood tests to aid growth
  • 10.3.3 FRANCE
    • 10.3.3.1 Growing number of new diagnostic tests and prevalence of cardiovascular diseases to drive market
  • 10.3.4 UK
    • 10.3.4.1 Increasing prevalence of lifestyle diseases and HIV to spur growth
  • 10.3.5 ITALY
    • 10.3.5.1 Rising blood donation to contribute to growth
  • 10.3.6 SPAIN
    • 10.3.6.1 Rise in organ transplants to aid growth
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 JAPAN
    • 10.4.2.1 Rapid increase in aging population to accelerate growth
  • 10.4.3 CHINA
    • 10.4.3.1 Growing demand for blood components to facilitate growth
  • 10.4.4 INDIA
    • 10.4.4.1 Rise in government initiatives for healthcare infrastructure to accelerate growth
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Growing emphasis on improving access to diagnostic and preventive healthcare to fuel market
  • 10.4.6 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 PREVALENCE OF INFECTIOUS DISEASES AND GROWING HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
  • 10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF KEY STRATEGIES DEPLOYED BY MAJOR PLAYERS
• 11.3 REVENUE ANALYSIS, 2022-2024
• 11.4 MARKET SHARE ANALYSIS, 2024
• 11.5 COMPANY VALUATION AND FINANCIAL METRICS
• 11.6 BRAND/PRODUCT COMPARISON
• 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 11.7.1 STARS
  • 11.7.2 EMERGING LEADERS
  • 11.7.3 PERVASIVE PLAYERS
  • 11.7.4 PARTICIPANTS
  • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 11.7.5.1 Company footprint
    • 11.7.5.2 Region footprint
    • 11.7.5.3 Product footprint
    • 11.7.5.4 Application footprint
    • 11.7.5.5 Method footprint
• 11.8 COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • 11.8.1 PROGRESSIVE COMPANIES
  • 11.8.2 RESPONSIVE COMPANIES
  • 11.8.3 DYNAMIC COMPANIES
  • 11.8.4 STARTING BLOCKS
  • 11.8.5 COMPETITIVE BENCHMARKING
    • 11.8.5.1 Detailed list of key startups/SMEs
    • 11.8.5.2 Competitive benchmarking of key startups/SMEs
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES AND APPROVALS
  • 11.9.2 DEALS
  • 11.9.3 EXPANSIONS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 BECTON, DICKINSON AND COMPANY (BD)
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches and approvals
      • 12.1.1.3.2 Expansions
      • 12.1.1.3.3 Deals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses and competitive threats
  • 12.1.2 TERUMO BCT, INC.
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Deals
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses and competitive threats
  • 12.1.3 FRESENIUS KABI AG
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product launches and approvals
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses and competitive threats
  • 12.1.4 GRIFOLS, S.A.
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
  • 12.1.5 NIPRO CORPORATION
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
  • 12.1.6 SARSTEDT AG & CO. KG
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
  • 12.1.7 MACOPHARMA
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
  • 12.1.8 HAEMONETICS CORPORATION
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Deals
      • 12.1.8.3.2 Product launches and approvals
      • 12.1.8.3.3 Expansions
  • 12.1.9 ICU MEDICAL, INC.
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
  • 12.1.10 CARDINAL HEALTH
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
  • 12.1.11 RETRACTABLE TECHNOLOGIES, INC.
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products offered
  • 12.1.12 GREINER HOLDING AG
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products offered
• 12.2 OTHER PLAYERS
  • 12.2.1 LIUYANG SANLI MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD.
  • 12.2.2 FL MEDICAL S.R.L.
  • 12.2.3 AB MEDICAL CO., LTD.
  • 12.2.4 APTACA SPA
  • 12.2.5 JIANGSU MICSAFE MEDICAL TECHNOLOGY CO., LTD.
  • 12.2.6 DISERA TIBBI MALZEME LOJISTIK SANAYI VE TICARET A.S
  • 12.2.7 AJOSHA BIO TEKNIK PVT. LTD.
  • 12.2.8 PREQ SYSTEMS
  • 12.2.9 CML BIOTECH LTD
  • 12.2.10 LMB TECHNOLOGIE GMBH
  • 12.2.11 MITRA INDUSTRIES PRIVATE LIMITED
  • 12.2.12 NEOMEDIC LIMITED
  • 12.2.13 MHC MEDICAL PRODUCTS, LLC

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS

List of Tables

• TABLE 1 BLOOD COLLECTION DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES
• TABLE 2 BLOOD COLLECTION DEVICES MARKET: RISK ANALYSIS
• TABLE 3 AVERAGE SELLING PRICING TREND OF BLOOD COLLECTION TUBES AND LANCETS, 2023-2025 (USD)
• TABLE 4 AVERAGE SELLING PRICE TREND OF BLOOD COLLECTION DEVICES, BY KEY PLAYER, 2023-2025 (USD)
• TABLE 5 AVERAGE SELLING PRICE TREND OF BLOOD COLLECTION DEVICES, BY REGION, 2023-2025 (USD)
• TABLE 6 BLOOD COLLECTION DEVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM
• TABLE 7 BLOOD COLLECTION DEVICES MARKET: LIST OF MAJOR PATENTS, 2023-2025
• TABLE 8 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2019-2023 (USD MILLION)
• TABLE 9 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018-2022 (USD MILLION)
• TABLE 10 BLOOD COLLECTION DEVICES MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
• TABLE 11 EUROPE: CLASSIFICATION OF DEVICES
• TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
• TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 17 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 18 BLOOD COLLECTION DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)
• TABLE 20 KEY BUYING CRITERIA, BY END USER
• TABLE 21 RECIPROCAL TARIFF RATES ADJUSTED BY US
• TABLE 22 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 23 BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 24 BLOOD COLLECTION TUBES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 25 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 26 EUROPE: BLOOD COLLECTION TUBES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 27 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 28 PLASMA/WHOLE-BLOOD TUBES AVAILABLE IN MARKET
• TABLE 29 BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 30 BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 31 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 32 EUROPE: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 33 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 34 EDTA TUBES AVAILABLE IN MARKET
• TABLE 35 BLOOD COLLECTION TUBES MARKET FOR EDTA TUBES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 36 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR EDTA TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 37 EUROPE: BLOOD COLLECTION TUBES MARKET FOR EDTA TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 38 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR EDTA TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 39 HEPARIN TUBES AVAILABLE IN MARKET
• TABLE 40 BLOOD COLLECTION TUBES MARKET FOR HEPARIN TUBES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 41 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR HEPARIN TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 42 EUROPE: BLOOD COLLECTION TUBES MARKET FOR HEPARIN TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 43 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR HEPARIN TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 44 COAGULATION TUBES AVAILABLE IN MARKET
• TABLE 45 BLOOD COLLECTION TUBES MARKET FOR COAGULATION TUBES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 46 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR COAGULATION TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 47 EUROPE: BLOOD COLLECTION TUBES MARKET FOR COAGULATION TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 48 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR COAGULATION TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 49 GLUCOSE TUBES AVAILABLE IN MARKET
• TABLE 50 BLOOD COLLECTION TUBES MARKET FOR GLUCOSE TUBES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 51 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR GLUCOSE TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 52 EUROPE: BLOOD COLLECTION TUBES MARKET FOR GLUCOSE TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 53 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR GLUCOSE TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 54 ESR TUBES AVAILABLE IN MARKET
• TABLE 55 BLOOD COLLECTION TUBES MARKET FOR ESR TUBES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 56 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR ESR TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 57 EUROPE: BLOOD COLLECTION TUBES MARKET FOR ESR TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 58 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR ESR TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 59 SERUM TUBES AVAILABLE IN MARKET
• TABLE 60 BLOOD COLLECTION TUBES MARKET FOR SERUM TUBES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 61 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR SERUM TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 62 EUROPE: BLOOD COLLECTION TUBES MARKET FOR SERUM TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 63 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR SERUM TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 64 BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 65 VACUUM TUBES AVAILABLE IN MARKET
• TABLE 66 BLOOD COLLECTION TUBES MARKET FOR VACUUM TUBES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 67 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR VACUUM TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 68 EUROPE: BLOOD COLLECTION TUBES MARKET FOR VACUUM TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 69 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR VACUUM TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 70 NON-VACUUM TUBES AVAILABLE IN MARKET
• TABLE 71 BLOOD COLLECTION TUBES MARKET FOR NON-VACUUM TUBES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 72 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR NON-VACUUM TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 73 EUROPE: BLOOD COLLECTION TUBES MARKET FOR NON-VACUUM TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 74 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR NON-VACUUM TUBES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 75 NEEDLES & SYRINGES AVAILABLE IN MARKET
• TABLE 76 BLOOD COLLECTION DEVICES MARKET FOR NEEDLES & SYRINGES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 77 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR NEEDLES & SYRINGES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 78 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR NEEDLES & SYRINGES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 79 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR NEEDLES & SYRINGES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 80 BLOOD BAGS AVAILABLE IN MARKET
• TABLE 81 BLOOD COLLECTION DEVICES MARKET FOR BLOOD BAGS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 82 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BAGS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 83 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BAGS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 84 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BAGS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 85 BLOOD COLLECTION SYSTEMS/MONITORS AVAILABLE IN MARKET
• TABLE 86 BLOOD COLLECTION DEVICES MARKET FOR BLOOD COLLECTION SYSTEMS/MONITORS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 87 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR BLOOD COLLECTION SYSTEMS/MONITORS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 88 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR BLOOD COLLECTION SYSTEMS/MONITORS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 89 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR BLOOD COLLECTION SYSTEMS/MONITORS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 90 LANCETS AVAILABLE IN MARKET
• TABLE 91 BLOOD COLLECTION DEVICES MARKET FOR LANCETS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 92 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR LANCETS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 93 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR LANCETS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 94 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR LANCETS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 95 GLOBAL NUMBER OF LANCETS MANUFACTURED, 2023-2030 (UNITS)
• TABLE 96 BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 97 BLOOD COLLECTION DEVICES MARKET FOR MANUAL BLOOD COLLECTION, BY REGION, 2023-2030 (USD MILLION)
• TABLE 98 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR MANUAL BLOOD COLLECTION, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 99 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR MANUAL BLOOD COLLECTION, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 100 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR MANUAL BLOOD COLLECTION, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 101 BLOOD COLLECTION DEVICES MARKET FOR AUTOMATED BLOOD COLLECTION, BY REGION, 2023-2030 (USD MILLION)
• TABLE 102 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR AUTOMATED BLOOD COLLECTION, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 103 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR AUTOMATED BLOOD COLLECTION, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 104 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR AUTOMATED BLOOD COLLECTION, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 105 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 106 REGIONAL HIV DATA, 2024
• TABLE 107 BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 108 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 109 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 110 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 111 BLOOD COLLECTION DEVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 112 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 113 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 114 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 115 BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 116 BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 117 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 118 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 119 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 120 BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 121 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 122 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 123 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 124 BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 125 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 126 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 127 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 128 BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 129 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 130 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 131 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 132 BLOOD COLLECTION DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 133 NORTH AMERICA: MACROECONOMIC INDICATORS
• TABLE 134 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 135 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 136 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 137 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 138 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 139 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 140 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 141 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 142 US: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 143 US: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 144 US: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 145 US: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 146 US: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 147 US: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 148 US: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 149 SURGICAL PROCEDURES PERFORMED IN CANADA, 2024
• TABLE 150 CANADA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 151 CANADA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 152 CANADA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 153 CANADA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 154 CANADA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 155 CANADA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 156 CANADA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 157 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 158 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 159 EUROPE: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 160 EUROPE: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 161 EUROPE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 162 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 163 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 164 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 165 SURGICAL PROCEDURES PERFORMED IN GERMANY, 2024
• TABLE 166 GERMANY: KEY MACROECONOMIC INDICATORS
• TABLE 167 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 168 GERMANY: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 169 GERMANY: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 170 GERMANY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 171 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 172 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 173 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 174 SURGICAL PROCEDURES PERFORMED IN FRANCE, 2024
• TABLE 175 FRANCE: KEY MACROECONOMIC INDICATORS
• TABLE 176 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 177 FRANCE: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 178 FRANCE: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 179 FRANCE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 180 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 181 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 182 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 183 SURGICAL PROCEDURES PERFORMED IN UK, 2024
• TABLE 184 UK: KEY MACROECONOMIC INDICATORS
• TABLE 185 UK: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 186 UK: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 187 UK: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 188 UK: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 189 UK: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 190 UK: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 191 UK: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 192 SURGICAL PROCEDURES PERFORMED IN ITALY, 2024
• TABLE 193 ITALY: KEY MACROECONOMIC INDICATORS
• TABLE 194 ITALY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 195 ITALY: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 196 ITALY: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 197 ITALY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 198 ITALY: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 199 ITALY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 200 ITALY: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 201 SURGICAL PROCEDURES PERFORMED IN SPAIN, 2024
• TABLE 202 SPAIN: KEY MACROECONOMIC INDICATORS
• TABLE 203 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 204 SPAIN: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 205 SPAIN: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 206 SPAIN: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 207 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 208 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 209 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 210 REST OF EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2020 VS. 2024 (% OF GDP)
• TABLE 211 PERCENTAGE OF POPULATION AGED 60 YEARS OR OVER, 2017 VS. 2050
• TABLE 212 SURGICAL PROCEDURES PERFORMED IN SWITZERLAND, 2024
• TABLE 213 REST OF EUROPE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 214 REST OF EUROPE: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 215 REST OF EUROPE: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 216 REST OF EUROPE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 217 REST OF EUROPE: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 218 REST OF EUROPE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 219 REST OF EUROPE: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 220 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 221 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 222 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 223 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 224 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 225 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 226 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 227 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 228 JAPAN: KEY MACROECONOMIC INDICATORS
• TABLE 229 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 230 JAPAN: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 231 JAPAN: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 232 JAPAN: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 233 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 234 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 235 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 236 CHINA: KEY MACROECONOMIC INDICATORS
• TABLE 237 CHINA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 238 CHINA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 239 CHINA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 240 CHINA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 241 CHINA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 242 CHINA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 243 CHINA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 244 INDIA: KEY MACROECONOMIC INDICATORS
• TABLE 245 INDIA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 246 INDIA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 247 INDIA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 248 INDIA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 249 INDIA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 250 INDIA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 251 INDIA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 252 AUSTRALIA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 253 AUSTRALIA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 254 AUSTRALIA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 255 AUSTRALIA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 256 AUSTRALIA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 257 AUSTRALIA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 258 AUSTRALIA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 259 SURGICAL PROCEDURES IN SOUTH KOREA, 2024
• TABLE 260 REST OF ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 261 REST OF ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 262 REST OF ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 263 REST OF ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 264 REST OF ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 265 REST OF ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 266 REST OF ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 267 LATIN AMERICA: KEY MACROECONOMIC INDICATORS
• TABLE 268 LATIN AMERICA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 269 LATIN AMERICA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 270 LATIN AMERICA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 271 LATIN AMERICA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 272 LATIN AMERICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 273 LATIN AMERICA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 274 LATIN AMERICA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 275 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS
• TABLE 276 MIDDLE EAST & AFRICA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 277 MIDDLE EAST & AFRICA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 278 MIDDLE EAST & AFRICA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 279 MIDDLE EAST & AFRICA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023-2030 (USD MILLION)
• TABLE 280 MIDDLE EAST & AFRICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023-2030 (USD MILLION)
• TABLE 281 MIDDLE EAST & AFRICA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 282 MIDDLE EAST & AFRICA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 283 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BLOOD COLLECTION DEVICES MARKET, JANUARY 2022-JUNE 2025
• TABLE 284 BLOOD COLLECTION DEVICES MARKET: DEGREE OF COMPETITION
• TABLE 285 BLOOD COLLECTION DEVICES MARKET: REGION FOOTPRINT
• TABLE 286 BLOOD COLLECTION DEVICES MARKET: PRODUCT FOOTPRINT
• TABLE 287 BLOOD COLLECTION DEVICES MARKET: APPLICATION FOOTPRINT
• TABLE 288 BLOOD COLLECTION DEVICES MARKET: METHOD FOOTPRINT
• TABLE 289 BLOOD COLLECTION DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
• TABLE 290 BLOOD COLLECTION DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY PRODUCT AND METHOD
• TABLE 291 BLOOD COLLECTION DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY REGION
• TABLE 292 BLOOD COLLECTION DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-JULY 2025
• TABLE 293 BLOOD COLLECTION DEVICES MARKET: DEALS, JANUARY 2022-JULY 2025
• TABLE 294 BLOOD COLLECTION DEVICES MARKET: EXPANSIONS, JANUARY 2022-JULY 2025
• TABLE 295 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW
• TABLE 296 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED
• TABLE 297 BECTON, DICKINSON AND COMPANY (BD): PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-JULY 2025
• TABLE 298 BECTON, DICKINSON AND COMPANY (BD): EXPANSIONS, JANUARY 2022-JULY 2025
• TABLE 299 BECTON, DICKINSON AND COMPANY (BD): DEALS, JANUARY 2022-JULY 2025
• TABLE 300 TERUMO BCT, INC.: COMPANY OVERVIEW
• TABLE 301 EXCHANGE RATES USED FOR CONVERSION OF YEN TO USD, 2022-2024
• TABLE 302 TERUMO BCT, INC.: PRODUCTS OFFERED
• TABLE 303 TERUMO BCT, INC.: DEALS, JANUARY 2022-JULY 2025
• TABLE 304 FRESENIUS KABI AG: COMPANY OVERVIEW
• TABLE 305 EXCHANGE RATES USED FOR CONVERSION OF EURO TO USD, 2022-2024
• TABLE 306 FRESENIUS KABI AG: PRODUCTS OFFERED
• TABLE 307 FRESENIUS KABI AG: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-JULY 2025
• TABLE 308 GRIFOLS, S.A.: COMPANY OVERVIEW
• TABLE 309 GRIFOLS, S.A.: PRODUCTS OFFERED
• TABLE 310 NIPRO CORPORATION: BUSINESS OVERVIEW
• TABLE 311 NIPRO CORPORATION: PRODUCTS OFFERED
• TABLE 312 SARSTEDT AG & CO. KG: COMPANY OVERVIEW
• TABLE 313 SARSTEDT AG & CO. KG: PRODUCTS OFFERED
• TABLE 314 MACOPHARMA: COMPANY OVERVIEW
• TABLE 315 MACOPHARMA: PRODUCTS OFFERED
• TABLE 316 HAEMONETICS CORPORATION: COMPANY OVERVIEW
• TABLE 317 HAEMONETICS CORPORATION: PRODUCTS OFFERED
• TABLE 318 HAEMONETICS CORPORATION: DEALS, JANUARY 2022-JULY 2025
• TABLE 319 HAEMONETICS CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-JULY 2025
• TABLE 320 HAEMONETICS CORPORATION: EXPANSIONS, JANUARY 2022-JULY 2025
• TABLE 321 ICU MEDICAL, INC.: COMPANY OVERVIEW
• TABLE 322 ICU MEDICAL, INC.: PRODUCTS OFFERED
• TABLE 323 CARDINAL HEALTH: COMPANY OVERVIEW
• TABLE 324 CARDINAL HEALTH: PRODUCTS OFFERED
• TABLE 325 RETRACTABLE TECHNOLOGIES, INC.: COMPANY OVERVIEW
• TABLE 326 RETRACTABLE TECHNOLOGIES, INC.: PRODUCTS OFFERED
• TABLE 327 GREINER HOLDING AG: COMPANY OVERVIEW
• TABLE 328 GREINER HOLDING AG: PRODUCTS OFFERED
• TABLE 329 LIUYANG SANLI MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD.: COMPANY OVERVIEW
• TABLE 330 FL MEDICAL S.R.L.: COMPANY OVERVIEW
• TABLE 331 AB MEDICAL CO., LTD.: COMPANY OVERVIEW
• TABLE 332 APTACA SPA: COMPANY OVERVIEW
• TABLE 333 JIANGSU MICSAFE MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
• TABLE 334 DISERA TIBBI MALZEME LOJISTIK SANAYI VE TICARET A.S: COMPANY OVERVIEW
• TABLE 335 AJOSHA BIO TEKNIK PVT. LTD.: COMPANY OVERVIEW
• TABLE 336 PREQ SYSTEMS: COMPANY OVERVIEW
• TABLE 337 CML BIOTECH LTD: COMPANY OVERVIEW
• TABLE 338 LMB TECHNOLOGIE GMBH: COMPANY OVERVIEW
• TABLE 339 MITRA INDUSTRIES PRIVATE LIMITED: COMPANY OVERVIEW
• TABLE 340 NEOMEDIC LIMITED: COMPANY OVERVIEW
• TABLE 341 MHC MEDICAL PRODUCTS, LLC: COMPANY OVERVIEW

List of Figures

• FIGURE 1 BLOOD COLLECTION DEVICES MARKET SEGMENTATION AND REGIONAL SCOPE
• FIGURE 2 RESEARCH DESIGN
• FIGURE 3 BLOOD COLLECTION DEVICES MARKET: KEY PRIMARY SOURCES
• FIGURE 4 BLOOD COLLECTION DEVICES MARKET: KEY INSIGHTS FROM PRIMARIES
• FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
• FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• FIGURE 7 BLOOD COLLECTION DEVICES MARKET: COMPANY REVENUE ESTIMATION APPROACH
• FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
• FIGURE 9 TOP-DOWN APPROACH
• FIGURE 10 DATA TRIANGULATION METHODOLOGY
• FIGURE 11 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
• FIGURE 12 BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2025 VS. 2030 (USD MILLION)
• FIGURE 13 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
• FIGURE 14 BLOOD COLLECTION DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
• FIGURE 15 BLOOD COLLECTION DEVICES MARKET, BY REGION, 2025 VS. 2030 (USD MILLION)
• FIGURE 16 INCREASING DISEASE INCIDENCE AND DEMAND FOR BLOOD COMPONENTS TO DRIVE MARKET
• FIGURE 17 BLOOD COLLECTION TUBES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
• FIGURE 18 MANUAL BLOOD COLLECTION SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
• FIGURE 19 DIAGNOSTIC APPLICATIONS SEGMENT TO SHOWCASE LARGEST MARKET SHARE DURING FORECAST PERIOD
• FIGURE 20 HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2030
• FIGURE 21 NORTH AMERICAN MARKET TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
• FIGURE 22 BLOOD COLLECTION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 23 INCREASING INCIDENCE OF DIABETES, 2021 VS. 2045 (MILLION)
• FIGURE 24 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
• FIGURE 26 SUPPLY CHAIN ANALYSIS: DIRECT DISTRIBUTION TO BE PREFERRED STRATEGY FOR PROMINENT COMPANIES
• FIGURE 27 BLOOD COLLECTION DEVICES MARKET: ECOSYSTEM ANALYSIS
• FIGURE 28 BLOOD COLLECTION DEVICES MARKET: INVESTMENT AND FUNDING SCENARIO, 2020-2023
• FIGURE 29 BLOOD COLLECTION DEVICES MARKET: PATENT ANALYSIS, JANUARY 2014-DECEMBER 2024
• FIGURE 30 BLOOD COLLECTION DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
• FIGURE 32 KEY BUYING CRITERIA, BY END USER
• FIGURE 33 AI USE CASES
• FIGURE 34 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET SNAPSHOT
• FIGURE 35 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET SNAPSHOT
• FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN BLOOD COLLECTION DEVICES MARKET, 2022-2024
• FIGURE 37 BLOOD COLLECTION DEVICES MARKET SHARE ANALYSIS, 2024
• FIGURE 38 EV/EBITDA OF KEY VENDORS
• FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
• FIGURE 40 BLOOD COLLECTION DEVICES MARKET: BRAND/PRODUCT COMPARISON
• FIGURE 41 BLOOD COLLECTION DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
• FIGURE 42 BLOOD COLLECTION DEVICES MARKET: COMPANY FOOTPRINT
• FIGURE 43 BLOOD COLLECTION DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
• FIGURE 44 BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT
• FIGURE 45 TERUMO BCT, INC.: COMPANY SNAPSHOT (2023)
• FIGURE 46 FRESENIUS KABI AG: COMPANY SNAPSHOT (2024)
• FIGURE 47 GRIFOLS, S.A.: COMPANY SNAPSHOT (2024)
• FIGURE 48 NIPRO CORPORATION: COMPANY SNAPSHOT (2024)
• FIGURE 49 HAEMONETICS CORPORATION: COMPANY SNAPSHOT (2024)
• FIGURE 50 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024)
• FIGURE 51 CARDINAL HEALTH: COMPANY SNAPSHOT (2024)
• FIGURE 52 RETRACTABLE TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)
• FIGURE 53 GREINER HOLDING AG: COMPANY SNAPSHOT (2024)